These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2445326)

  • 1. Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1987 Nov; 105(11):1499-507. PubMed ID: 2445326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of treatment extent on the visual acuity of eyes treated with Krypton laser for juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1995 Feb; 113(2):190-4. PubMed ID: 7532395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Krypton laser photocoagulation for idiopathic neovascular lesions. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1990 Jun; 108(6):832-7. PubMed ID: 1693498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Argon laser photocoagulation for ocular histoplasmosis. Results of a randomized clinical trial.
    Arch Ophthalmol; 1983 Sep; 101(9):1347-57. PubMed ID: 6193771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of recurrent juxtafoveal subretinal neovascular membranes with krypton red laser photocoagulation.
    Olk RJ; Burgess DB
    Ophthalmology; 1985 Aug; 92(8):1035-46. PubMed ID: 2413415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1990 Jun; 108(6):816-24. PubMed ID: 1693496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser photocoagulation for neovascular lesions nasal to the fovea. Results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1995 Jan; 113(1):56-61. PubMed ID: 7529993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1989 Mar; 107(3):344-52. PubMed ID: 2466454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Argon green vs krypton red laser photocoagulation for extrafoveal choroidal neovascularization. One-year results in ocular histoplasmosis. The Canadian Ophthalmology Study Group.
    Arch Ophthalmol; 1994 Sep; 112(9):1166-73. PubMed ID: 7522003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1994 Apr; 112(4):500-9. PubMed ID: 7512336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1996 Jun; 114(6):677-88. PubMed ID: 8639078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser treatment for choroidal neovascularization outside randomized clinical trials.
    Jost BF; Alexander MF; Maguire MG; Fine SL; Chamberlin JA; Murphy RP
    Arch Ophthalmol; 1988 Mar; 106(3):357-61. PubMed ID: 2449884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1991 Sep; 109(9):1220-31. PubMed ID: 1718250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1991 Aug; 109(8):1109-14. PubMed ID: 1714270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argon green vs krypton red laser photocoagulation of extrafoveal choroidal neovascular lesions. One-year results in age-related macular degeneration. The Canadian Ophthalmology Study Group.
    Arch Ophthalmol; 1993 Feb; 111(2):181-5. PubMed ID: 7679269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argon laser photocoagulation for idiopathic neovascularization. Results of a randomized clinical trial.
    Arch Ophthalmol; 1983 Sep; 101(9):1358-61. PubMed ID: 6193772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of argon green vs krypton red laser for photocoagulation of subfoveal choroidal neovascularization in the macular photocoagulation study. Macular Photocoagulation Study (MPS) Group.
    Arch Ophthalmol; 1994 Sep; 112(9):1176-84. PubMed ID: 7522004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internal limiting membrane wrinkling after argon and krypton laser photocoagulation of choroidal neovascularization.
    Han DP; Folk JC
    Retina; 1986; 6(4):215-9. PubMed ID: 2437625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1991 Sep; 109(9):1232-41. PubMed ID: 1718251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular histoplasmosis syndrome.
    Burgess DB
    Ophthalmology; 1986 Jul; 93(7):967-8. PubMed ID: 3531956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.